Cytokinetics
CYTK
CYTK
424 hedge funds and large institutions have $8.8B invested in Cytokinetics in 2025 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 143 increasing their positions, 132 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 132
4.51% less ownership
Funds ownership: 117.77% → 113.26% (-4.5%)
13% less funds holding in top 10
Funds holding in top 10: 16 → 14 (-2)
Holders
424
Holding in Top 10
14
Calls
$477M
Puts
$118M
Top Buyers
| 1 | +$54.1M | |
| 2 | +$45.8M | |
| 3 | +$32.9M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$32.9M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$28.5M |
Top Sellers
| 1 | -$84.9M | |
| 2 | -$59.9M | |
| 3 | -$41.8M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$39.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29.3M |
